Genscript Biotech Correlations

GNNSF Stock

USD 1.25 0.01 0.79%

The current 90-days correlation between Genscript Biotech and Innovent Biologics is -0.1 (i.e., Good diversification). The correlation of Genscript Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Genscript Biotech Correlation With Market

Average diversification

The correlation between Genscript Biotech and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Genscript Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genscript Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genscript Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genscript Biotech to buy it.

Moving together with Genscript Pink Sheet

0.71

MCAE

Mountain Crest Acqui

Pair Corr

Moving against Genscript Pink Sheet

0.68	SLF	Sun Life Financial	Pair Corr
0.43	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.34	SIGL	Signal Advance	Pair Corr
0.65	WMT	Walmart	Pair Corr
0.63	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.62	HD	Home Depot	Pair Corr
0.59	DIS	Walt Disney Sell-off Trend	Pair Corr
0.52	PYPL	PayPal Holdings Aggressive Push	Pair Corr
0.51	T	ATT Inc Sell-off Trend	Pair Corr
0.51	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.39	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr
0.38	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.35	CSCO	Cisco Systems	Pair Corr

Related Correlations Analysis

	TLPPF	KROS	ZNTL	IVBXF	CLRPF	ONTTF	NUVL	CRNX	INBX	MRUS
TLPPF		0.58	0.03	-0.35	-0.46	-0.16	-0.04	0.45	-0.45	-0.36	TLPPF
KROS	0.58		0.11	-0.29	-0.3	0.02	-0.05	0.54	0.15	0.14	KROS
ZNTL	0.03	0.11		-0.23	0.23	0.25	0.16	0.02	0.27	-0.13	ZNTL
IVBXF	-0.35	-0.29	-0.23		0.54	0.6	0.66	-0.57	0.2	0.39	IVBXF
CLRPF	-0.46	-0.3	0.23	0.54		0.59	0.41	-0.61	0.32	0.45	CLRPF
ONTTF	-0.16	0.02	0.25	0.6	0.59		0.65	-0.46	0.46	0.21	ONTTF
NUVL	-0.04	-0.05	0.16	0.66	0.41	0.65		-0.23	0.3	0.26	NUVL
CRNX	0.45	0.54	0.02	-0.57	-0.61	-0.46	-0.23		-0.04	0.05	CRNX
INBX	-0.45	0.15	0.27	0.2	0.32	0.46	0.3	-0.04		0.56	INBX
MRUS	-0.36	0.14	-0.13	0.39	0.45	0.21	0.26	0.05	0.56		MRUS
	TLPPF	KROS	ZNTL	IVBXF	CLRPF	ONTTF	NUVL	CRNX	INBX	MRUS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NUVL	+ 0.66	IVBXF
NUVL	+ 0.65	ONTTF
ONTTF	+ 0.6	IVBXF
ONTTF	+ 0.59	CLRPF
KROS	+ 0.58	TLPPF
MRUS	+ 0.56	INBX

High negative correlations

CRNX	- 0.61	CLRPF
CRNX	- 0.57	IVBXF
CRNX	- 0.46	ONTTF
CLRPF	- 0.46	TLPPF
INBX	- 0.45	TLPPF
MRUS	- 0.36	TLPPF

Risk-Adjusted Indicators

There is a big difference between Genscript Pink Sheet performing well and Genscript Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genscript Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TLPPF	2.89	0.43	0.10	6.02	2.82	(3.33)	5.78	(5.03)	17.87
KROS	2.39	0.18	0.10	0.21	2.38	(2.69)	6.18	(4.61)	14.47
ZNTL	4.19	0.01	0.03	0.12	5.10	(4.59)	11.41	(8.20)	33.76
IVBXF	1.64	0.00	0.00	0.11	0.00	0.00	4.92	(7.81)	24.34
CLRPF	4.10	(0.44)	0.00	1.85	0.00	0.00	11.14	(9.76)	27.06
ONTTF	4.14	0.10	0.02	0.22	4.21	(6.15)	12.03	(8.29)	25.17
NUVL	2.18	0.10	0.01	0.51	2.65	(2.54)	3.84	(4.61)	36.85
CRNX	1.63	0.09	0.01	0.30	2.48	(1.50)	2.74	(3.52)	16.75
INBX	2.14	(0.09)	(0.03)	0.03	2.69	(2.47)	4.92	(4.90)	16.07
MRUS	1.89	(0.33)	0.00	(0.16)	0.00	0.00	3.33	(3.83)	13.01

Be your own money manager

Our tools can tell you how much better you can do entering a position in Genscript Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sign In To Macroaxis Now

Sign In To Macroaxis

All Next

Launch Module

Genscript Biotech Corporate Management

Shiniu Wei	Chief Officer	Profile
Brian Min	CEO Bus	Profile
Zhenyu Liu	Chief Officer	Profile
Weihui Shao	Chief Officer	Profile
Chifa Zhang	Department head - industry synthetic biology product segment	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC